110 related articles for article (PubMed ID: 8156098)
1. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study.
Cucinotta D; De Luca F; Gigante A; Arrigo T; Di Benedetto A; Tedeschi A; Lombardo F; Romano G; Sferlazzas C
Eur J Endocrinol; 1994 Mar; 130(3):253-8. PubMed ID: 8156098
[TBL] [Abstract][Full Text] [Related]
2. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients.
De Luca F; Arrigo T; Di Benedetto A; Tedeschi A; Sferlazzas C; Crisafulli G; Di Cesare E; Romano G; Magazzù G; Cucinotta D
Horm Res; 1995; 44(2):45-50. PubMed ID: 7590631
[TBL] [Abstract][Full Text] [Related]
3. Insulin responses to intravenous glucose and the hyperglycemic clamp in cystic fibrosis patients with different degrees of glucose tolerance.
Rakotoambinina B; Delaisi B; Laborde K; Silly C; De Blic J; Lenoir G; Robert JJ
Pediatr Res; 1994 Nov; 36(5):667-71. PubMed ID: 7877889
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up.
Arrigo T; Cucinotta D; Conti Nibali S; Di Cesare E; Di Benedetto A; Magazzù G; De Luca F
Acta Paediatr; 1993 Mar; 82(3):249-53. PubMed ID: 8495078
[TBL] [Abstract][Full Text] [Related]
5. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.
Lombardo F; De Luca F; Rosano M; Sferlazzas C; Lucanto C; Arrigo T; Messina MF; Crisafulli G; Wasniewska M; Valenzise M; Cucinotta D
Eur J Endocrinol; 2003 Jul; 149(1):53-9. PubMed ID: 12824866
[TBL] [Abstract][Full Text] [Related]
6. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
8. Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?
Boudreau V; Coriati A; Hammana I; Ziai S; Desjardins K; Berthiaume Y; Rabasa-Lhoret R
J Cyst Fibros; 2016 Nov; 15(6):839-845. PubMed ID: 27139162
[TBL] [Abstract][Full Text] [Related]
9. Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.
Battezzati A; Mari A; Zazzeron L; Alicandro G; Claut L; Battezzati PM; Colombo C
Eur J Endocrinol; 2011 Jul; 165(1):69-76. PubMed ID: 21502328
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and exogenous insulin responses in patients with cystic fibrosis.
Wilmshurst EG; Soeldner JS; Holsclaw DS; Kaufmann RL; Shwachman H; Aoki TT; Gleason RE
Pediatrics; 1975 Jan; 55(1):75-82. PubMed ID: 1110865
[TBL] [Abstract][Full Text] [Related]
11. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis.
Cucinotta D; Arrigo T; De Luca F; Di Benedetto A; Lombardo F; Scoglio R; Sferlazzas C; Magazzù G
Eur J Endocrinol; 1996 Jun; 134(6):731-6. PubMed ID: 8766944
[TBL] [Abstract][Full Text] [Related]
13. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of insulin resistance in cystic fibrosis.
Hardin DS; Leblanc A; Marshall G; Seilheimer DK
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1022-8. PubMed ID: 11595659
[TBL] [Abstract][Full Text] [Related]
16. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Hinds A; Sheehan AG; Parsons HG
Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance is associated with decreased clinical status in cystic fibrosis.
Hardin DS; LeBlanc A; Lukenbough S; Seilheimer DK
J Pediatr; 1997 Jun; 130(6):948-56. PubMed ID: 9202618
[TBL] [Abstract][Full Text] [Related]
18. [Carbohydrate metabolic changes in cystic fibrosis].
García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous hypoglycemia in patients with cystic fibrosis.
Battezzati A; Battezzati PM; Costantini D; Seia M; Zazzeron L; Russo MC; Daccò V; Bertoli S; Crosignani A; Colombo C
Eur J Endocrinol; 2007 Mar; 156(3):369-76. PubMed ID: 17322497
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
